FDA Approved: NEXVIAZYME — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

FDA approved a supplemental application for NEXVIAZYME (avalglucosidase alfa-ngpt) submitted by Genzyme Corporation. This action updates the regulatory approval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Drugs mentioned

• NEXVIAZYME (avalglucosidase alfa)

Snippet

SUPPL AP for NEXVIAZYME (AVALGLUCOSIDASE ALFA-NGPT)